Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) | Zendy

Carl J. Pepine | Zendy; Peter F. Cohn | Zendy; Prakash Deedwania | Zendy; Robert S. Gibson | Zendy; Eileen Handberg | Zendy; James A. Hill | Zendy; Elizabeth Miller | Zendy; Ronald G. Marks | Zendy; Udho Thadani | Zendy

Open Access

Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)

Author(s) -

Carl J. Pepine,

Peter F. Cohn,

Prakash Deedwania,

Robert S. Gibson,

Eileen Handberg,

James A. Hill,

Elizabeth Miller,

Ronald G. Marks,

Udho Thadani

Publication year - 1994

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.90.2.762

Subject(s) - medicine , asymptomatic , ischemia , atenolol , angina , placebo , cardiology , ambulatory , adverse effect , coronary artery disease , myocardial infarction , randomized controlled trial , revascularization , anesthesia , blood pressure , alternative medicine , pathology

Detection of asymptomatic ischemia in patients with coronary artery disease has been associated with increased risk for adverse outcome, but treatment of patients with asymptomatic ischemia remains controversial. Accordingly, the purpose of this study was to determine if treatment reduces adverse outcome in patients with daily life ischemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research